FDA’s New Neuroscience Initiative Highlights the Importance of Early, Adaptive Patent Strategy
Key Takeaway: The FDA’s new neuroscience initiative is designed to accelerate a new wave of biotechnology innovation, and with it, new opportunities for intellectual property protection. For companies developing neuroscience...
Life Science Update | October 2026
FDA Launches Expedited IND Pilot Program to Accelerate Human Trials, Raising IP Considerations for Sponsors Joseph Mallon, Ph.D. & Susan M. Janicki, Ph.D. The Expedited Investigational New Drug (IND) Pilot...
Aerospace Vertical Integration: Turning Manufacturing Control Into an IP Advantage
Key Takeaways: Vertical integration and in-house manufacturing can provide aerospace companies with greater control over supply chains and manufacturing capacity while creating new opportunities for innovation. To maximize the value...
Subscribe for News and Updates